09Dec
09Dec
Hoth Therapeutics Licenses Lupus Therapeutic Back to Zylö Therapeutics
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs, is pleased to announce that it has entered into an agreement with Zylö Therapeutics to license its novel cannabinoid therapeutic, HT-005 for lupus patients, back to Zylö. Read more >>
09Dec
Zylö Therapeutics receives $300K investment from SC Launch
SC Launch Inc., South Carolina Research Authority (SCRA’s) investment affiliate, announced Dec. 7 it has invested $300,000 in Zylö Therapeutics Inc., a medical research business in Greenville. Read more >>
08Dec
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
Corbus Pharmaceuticals Holdings, Inc. today announced the appointment of Rachael Brake, Ph.D., as Chief Scientific Officer, furthering the Company's mission of connecting innovation to purpose. Dr. Brake will build upon Corbus' commitment to immuno-oncology and joins the Company following the recent acquisition of monoclonal antibodies that inhibit TGFβ activation. Dr. Brake formerly held leadership roles at Takeda Oncology, including Vice President, Global Project Leader in the Oncology Therapeutic Area and Head, U.S. Medical Affairs, Oncology Business Unit. Read more >>
08Dec
ZetrOZ Proudly Continues Sponsorship of Connecticut Whale Women’s Ice Hockey
ZetrOZ Systems, developer of the sam® sustained acoustic medicine device, is proud to announce its continued support of Danbury's professional women's ice hockey team, the Connecticut Whale of the Premier Hockey Federation. For the second consecutive year, ZetrOZ is supporting the Whale and women's hockey with its wearable ultrasound technology that revolutionizes soft tissue injury healing. The ZetrOZ pain relief ultrasound device delivers long-duration slow-release ultrasound and promotes healing without the need for potentially addictive painkillers or invasive surgery. Read...
07Dec
SMU and University of Virginia to play in Inaugural Wasabi Fenway Bowl
The SMU Mustangs and University of Virginia (UVA) Cavaliers will play each other in the inaugural Wasabi Fenway Bowl at Fenway Park on Wednesday, December 29 at 11 a.m. “The Wasabi Fenway Bowl will be a new landmark sporting tradition New England can be proud of, and we could not be more excited to have these two outstanding teams participating in the inaugural game at historic Fenway Park on December 29,” said Michael Welts, CMO of Wasabi Technologies. Read more >>
07Dec
SC Launch, Inc. Announces Third Investment in Zylö Therapeutics
South Carolina Research Authority (SCRA’s) investment affiliate, SC Launch, Inc. has made its third investment into Zylö Therapeutics, Inc. This $300,000 investment will help the company continue providing therapeutic topical solutions. Read more >>
05Dec
Trying to find admiration post-lock all the way down? Specific niche online dating software will be the after that larger thing
After an extended and lonely lockdown, Theresa Causa got ready for appreciate. To track down it, the 40-year-old nurse practitioner in San Antonio turned to the fresh internet dating app “S’More,” that will help people set right up by literally shifting the focus from bodily shows to shared plans and interests. When fits 1st link, they see just blurred models of each and every other’s visibility photographs, with bios, passions and solutions to prompts like “what exactly are your own...
04Dec
CT Biotech Firm Working Drug to Treat Stroke, Brain Injuries
Co-founded by William Korinek of Stonington, who spent nearly a decade at Pfizer, Astrocyte Pharmaceuticals expects to launch a phase one clinical trial of its leading drug candidate in the first half of 2022. Last week, Astrocyte put out word that Stroke, a peer-reviewed journal, had published the results of preclinical studies of the drug, known for now as AST-004. The lack of available treatments for stroke is a major unmet medical need, one that could qualify Astrocyte’s drug development...
04Dec